Sentences with phrase «new neurological research»
Causes & Cures reveals new neurological research about the root causes of these obstacles and lays out a comprehensive five - step protocol designed to help all educators identify and address common student academic and behavior issues.
http://www.ascd.org/ Not exact matches
«I think we are hard - wired to release our compassionate care when we see signs of vulnerability,» said Stephanie Brown, a psychologist researching neurological links between motherhood and altruism at Stony Brook University in New York.
But new research holds out hope that drugs developed to treat other neurological problems — notably epilepsy — could rein in the compulsive and blind drive to eat at the core of the disorder.
Her research is part of growing evidence that has yielded an entirely new understanding of molecular differences reflected in the brain between men and women, and how outside forces can permanently imprint neurological circuitry in sex - based ways.
Many studies have linked more sleep to better memory, but new research in fruit flies demonstrates that extra sleep helps the brain overcome catastrophic neurological defects that otherwise would block memory formation, report scientists at Washington University School of Medicine in St. Louis.
The neurological wiring that makes us feel pain, new research suggests, also means that a common painkiller could ease the sting.
Modern living could be responsible for an «almost epidemic» increase in neurological brain disease, according to new research from Bournemouth University.
Alcohol abuse does its neurological damage more quickly in women than in men, new research suggests.
Now, new research from the Salk Institute shows how a protein called p75 is critical for pain signaling, which could one day have implications for treating neurological disorders as well as trauma such as spinal cord injury.
Katerina Akassoglou, PhD, and her research team have uncovered a promising new therapeutic strategy for treating disabling neurological diseases.
Research primarily funded by the Rett Syndrome Research Trust (RSRT) and the National Institutes of Neurological Disease and Stroke (NINDS), and published in the journal Nature reveals important information that could lead to new treatment approaches.
New research by investigators at the University of Massachusetts Medical School suggests the immune system plays an unsuspected and surprising role in the progression of Rett syndrome, a severe neurological disorder affecting children.
Pozzo - Miller reflects that this new research on LM22A - 4, combined with prior studies from the Katz lab, provides hope that at least some neurological and cognitive deficits in individuals with Rett could be improved by pharmacological treatment even after the onset of symptoms.
«These exciting results provide new hope for developing drugs against an important molecular target in the brain,» said Roderick Corriveau, program director at the National Institute of Neurological Disorders and Stroke, which helped support the research.
New research from University of Liverpool scientists has cast doubt on the theory that neurological behaviour is a product of culture in people of Chinese origin.
«This study opens a promising new avenue of research into treatments that may prevent the development of epilepsy,» said Vicky Whittemore, PhD, a program director at the National Institute of Neurological Disorders and Stroke, who oversees the grants that funded this study.
«This result has strong application potential» says Dr. Parise, who has just accepted a new position as research scientist at Oculus VR (Facebook): «A deep understanding of multisensory processing opens new clinical perspectives for neurological syndromes that are associated with multisensory impairments, such as Autism Spectrum Disorder and Dyslexia.
«The grim prognosis is exactly why new research is important,» said Bloch, who is an assistant professor of neurological surgery at the Northwestern Feinberg School of Medicine.
«When it comes to brain tumor research, I picture our Northwestern Medicine team climbing a mountain and with every new discovery that shows the potential to prolong survival, we are establishing a new base camp,» said Andrew Parsa, MD, corresponding author of the study and chair of neurological surgery at Northwestern Memorial and the Michael J. Marchese Professor and chair of the department of neurological surgery at the Feinberg School.
New research has also begun at NYU Langone to test tDCS for other neurological conditions, including Parkinson's disease.
Now that scientists can explain the neurological symptoms that characterize GWI, a new paradigm of research has been unlocked — one related to treatment options.
It may also open up new research avenues in exploring the function of the healthy brain and the study of neurological diseases.»
New research by Vladimir Litvak, PhD, assistant professor of microbiology & physiological systems, suggests the immune system plays an unsuspected and surprising role in the progression of Rett syndrome, a severe neurological disorder affecting children.
The overall goal of this research is to provide new insight into the function and dysfunction of human neural cell populations in aging and neurological disorders, such as LOAD, and to identify mechanisms and molecules that can be translated to developing and testing novel diagnostic tools and therapeutics.
The findings, published today in the online journal PloS One, open new opportunities for gaining a greater understanding of Alzheimer's disease and other neurological diseases and for developing therapies to halt its progression, according to senior author Karen E. Duff, PhD, professor of pathology (in psychiatry and in the Taub Institute for Research on Alzheimer's Disease and the Aging Brain) at CUMC and at the New York State Psychiatric Institunew opportunities for gaining a greater understanding of Alzheimer's disease and other neurological diseases and for developing therapies to halt its progression, according to senior author Karen E. Duff, PhD, professor of pathology (in psychiatry and in the Taub Institute for Research on Alzheimer's Disease and the Aging Brain) at CUMC and at the New York State Psychiatric InstituNew York State Psychiatric Institute.
Strategically located adjacent to UCSF's renowned Mission Bay biomedical research campus, the new medical center places UCSF physicians in close proximity to UCSF researchers and nearby bioscience companies who are working to understand and treat a range of diseases, from cancer to neurological disorders.
Inspired by a grandfather who had Alzheimer's disease, Dr. Mucke founded Gladstone's neurological research program 15 years ago and today leads more than 100 students, postdocs, research scientists and principal investigators in the search for new understanding of and therapies for some of the world's most devastating illnesses — including Alzheimer's, Parkinson's, ALS, and multiple sclerosis.
Issam Awad, MD, director of neurovascular surgery at the University of Chicago Medicine, will lead a new program that melds the latest neuroscience research with clinical practice to improve care for patients with neurological diseases.
The research offers new hope in the fight against many neurological conditions because scientists expect that such a transformation — or reprogramming — of cells may lead to better models for testing drugs for devastating neurodegenerative conditions such as Alzheimer's disease.
These highly competitive funds enable UCSF scientists to pursue research aimed at advancing understanding of human health and disease, and developing new therapies for neurological diseases, cancer, diabetes, cardiovascular disease, and a host of other conditions.
Katerina Akassoglou's research on the brain's vascular and immune systems has led to new insights about multiple sclerosis and other neurological conditions.
NIH's National Institute of Neurological Disorders and Stroke (NINDS) has issued a request for applications for its new Research Program Award (RPA), which is designed to...
«Our research on the role of blood proteins in brain functions has identified new targets for therapeutic intervention in multiple sclerosis and other neurological diseases,» said Dr. Akassoglou.
At the Gladstone Institutes, neuroscientists rely on the Behavioral Core to research brain functions in both healthy and disease states, investigating the causes of neurological disorders and creating new therapies to overcome them.
Merzenich is now applying his basic research findings to the development and testing of new tools for improving brain function in people with a range of neurological and psychiatric conditions, such as Alzheimer's disease or schizophrenia, or following brain injury.
The potential benefits of primate research include an improved understanding of cancer, infectious diseases, neurological disorders, spinal cord injuries, basic biological and behavioral processes, and the development of new medicines, vaccines, devices and other treatments, according to scientific researchers.
Susan Amara, USA - «Regulation of transporter function and trafficking by amphetamines, Structure - function relationships in excitatory amino acid transporters (EAATs), Modulation of dopamine transporters (DAT) by GPCRs, Genetics and functional analyses of human trace amine receptors» Tom I. Bonner, USA (Past Core Member)- Genomics, G protein coupled receptors Michel Bouvier, Canada - Molecular Pharmacology of G protein - Coupled Receptors; Molecular mechanisms controlling the selectivity and efficacy of GPCR signalling Thomas Burris, USA - Nuclear Receptor Pharmacology and Drug Discovery William A. Catterall, USA (Past Core Member)- The Molecular Basis of Electrical Excitability Steven Charlton, UK - Molecular Pharmacology and Drug Discovery Moses Chao, USA - Mechanisms of Neurotophin Receptor Signaling Mark Coles, UK - Cellular differentiation, human embryonic stem cells, stromal cells, haematopoietic stem cells, organogenesis, lymphoid microenvironments, develomental immunology Steven L. Colletti, USA Graham L Collingridge, UK Philippe Delerive, France - Metabolic Research (diabetes, obesity, non-alcoholic fatty liver, cardio - vascular diseases, nuclear hormone receptor, GPCRs, kinases) Sir Colin T. Dollery, UK (Founder and Past Core Member) Richard M. Eglen, UK Stephen M. Foord, UK David Gloriam, Denmark - GPCRs, databases, computational drug design, orphan recetpors Gillian Gray, UK Debbie Hay, New Zealand - G protein - coupled receptors, peptide receptors, CGRP, Amylin, Adrenomedullin, Migraine, Diabetes / obesity Allyn C. Howlett, USA Franz Hofmann, Germany - Voltage dependent calcium channels and the positive inotropic effect of beta adrenergic stimulation; cardiovascular function of cGMP protein kinase Yu Huang, Hong Kong - Endothelial and Metabolic Dysfunction, and Novel Biomarkers in Diabetes, Hypertension, Dyslipidemia and Estrogen Deficiency, Endothelium - derived Contracting Factors in the Regulation of Vascular Tone, Adipose Tissue Regulation of Vascular Function in Obesity, Diabetes and Hypertension, Pharmacological Characterization of New Anti-diabetic and Anti-hypertensive Drugs, Hypotensive and antioxidant Actions of Biologically Active Components of Traditional Chinese Herbs and Natural Plants including Polypehnols and Ginsenosides Adriaan P. IJzerman, The Netherlands - G protein - coupled receptors; allosteric modulation; binding kinetics Michael F Jarvis, USA - Purines and Purinergic Receptors and Voltage-gated ion channel (sodium and calcium) pharmacology Pain mechanisms Research Reproducibility Bong - Kiun Kaang, Korea - G protein - coupled receptors; Glutamate receptors; Neuropsychiatric disorders Eamonn Kelly, Prof, UK - Molecular Pharmacology of G protein - coupled receptors, in particular opioid receptors, regulation of GPCRs by kinasis and arrestins Terry Kenakin, USA - Drug receptor pharmacodynamics, receptor theory Janos Kiss, Hungary - Neurodegenerative disorders, Alzheimer's disease Stefan Knapp, Germany - Rational design of highly selective inhibitors (so call chemical probes) targeting protein kinases as well as protein interaction inhibitors of the bromodomain family Andrew Knight, UK Chris Langmead, Australia - Drug discovery, GPCRs, neuroscience and analytical pharmacology Vincent Laudet, France (Past Core Member)- Evolution of the Nuclear Receptor / Ligand couple Margaret R. MacLean, UK - Serotonin, endothelin, estrogen, microRNAs and pulmonary hyperten Neil Marrion, UK - Calcium - activated potassium channels, neuronal excitability Fiona Marshall, UK - GPCR molecular pharmacology, structure and drug discovery Alistair Mathie, UK - Ion channel structure, function and regulation, pain and the nervous system Ian McGrath, UK - Adrenoceptors; autonomic transmission; vascular pharmacology Graeme Milligan, UK - Structure, function and regulation of G protein - coupled receptors Richard Neubig, USA (Past Core Member)- G protein signaling; academic drug discovery Stefan Offermanns, Germany - G protein - coupled receptors, vascular / metabolic signaling Richard Olsen, USA - Structure and function of GABA - A receptors; mode of action of GABAergic drugs including general anesthetics and ethanol Jean - Philippe Pin, France (Past Core Member)- GPCR - mGLuR - GABAB - structure function relationship - pharmacology - biophysics Helgi Schiöth, Sweden David Searls, USA - Bioinformatics Graeme Semple, USA - GPCR Medicinal Chemistry Patrick M. Sexton, Australia - G protein - coupled receptors Roland Staal, USA - Microglia and neuroinflammation in neuropathic pain and neurological disorders Bart Staels, France - Nuclear receptor signaling in metabolic and cardiovascular diseases Katerina Tiligada, Greece - Immunopharmacology, histamine, histamine receptors, hypersensitivity, drug allergy, inflammation Georg Terstappen, Germany - Drug discovery for neurodegenerative diseases with a focus on AD Mary Vore, USA - Activity and regulation of expression and function of the ATP - binding cassette (ABC) transporters
The National Institute of Neurological Disease and Stroke recently designated spinal muscular atrophy as the model for its new approach to funding «translational research.»
, who directs neurological research at the Gladstone Institutes, today received the MetLife Foundation's 2013 Award for Medical Research in Alzheimer's Disease at a scientific briefing and awards ceremony in Nresearch at the Gladstone Institutes, today received the MetLife Foundation's 2013 Award for Medical Research in Alzheimer's Disease at a scientific briefing and awards ceremony in NResearch in Alzheimer's Disease at a scientific briefing and awards ceremony in New York.
SAN FRANCISCO, CA — Lennart Mucke, MD, who directs neurological research at the Gladstone Institutes, today received the MetLife Foundation's 2013 Award for Medical Research in Alzheimer's Disease at a scientific briefing and awards ceremony in Nresearch at the Gladstone Institutes, today received the MetLife Foundation's 2013 Award for Medical Research in Alzheimer's Disease at a scientific briefing and awards ceremony in NResearch in Alzheimer's Disease at a scientific briefing and awards ceremony in New York.
April 26, 2017 New UChicago Medicine program to advance care for neurological diseases Issam Awad, MD, director of neurovascular surgery at the University of Chicago Medicine, will lead a new program that melds the latest neuroscience research with clinical practice to improve care for patients with neurological diseasNew UChicago Medicine program to advance care for neurological diseases Issam Awad, MD, director of neurovascular surgery at the University of Chicago Medicine, will lead a new program that melds the latest neuroscience research with clinical practice to improve care for patients with neurological diseasnew program that melds the latest neuroscience research with clinical practice to improve care for patients with neurological diseases.
The National Institute of Neurological Disorders and Stroke (NINDS) has selected SMA to serve as the prototype for a translational research project that is expected to yield drug candidates for investigational new drug application filings by 2007.
Dr. Fasano shows how celiac disease can have effects on all areas of the body, not just the digestive system, and discusses new research on the neurological and psychiatric / behavioral effects of gluten.
Ketogenic diets — extreme low - carbohydrate, high - fat regimens that have long been known to benefit epilepsy and other neurological illnesses — may work by lowering inflammation in the brain, according to new research by UC San Francisco scientists.
However, newer research has confirmed the validity of non-celiac gluten sensitivity, an immune response to gluten that causes many symptoms, including digestive problems, skin rashes, joint pain, and neurological and psychiatric diseases.
This opens doors to entirely new areas of brain research related to understanding lactate's specific neurological effects that could lead to new treatments for common brain ailments, the researchers said in a statement today.
An active member of Portland - based artist collective Appendix, which is known as much for intellectual engagement as physical practice, his current research explores the resonance of new visual technologies with deep - rooted neurological processes.
N / C Machine Operator N / C Programmer Nanny National Sales Manager (Experience) Navigator Aircraft Needleworker Neonatologist Nephrologist Network Analyst Computer Network Architect Network Communications Technician Network Control Manager Network Control Supervisor Network Control Technician Network Planning Analyst Network Planning Manager Network Planning Supervisor Network / Data Communications Manager Neurological Technologist Neurologist Neurosurgeon New Accounts Representative Financial New - Car Prep Mechanic News Anchor News Assistant News Correspondent News Gathering Technician News Librarian News Photographer News Reporter Newscaster Newspaper Delivery Driver Newspaper Editor - In - Chief Nibbler Operator Nondestructive Tester Note Teller Nuclear Criticality Safety Engineer Nuclear Engineer Nuclear Equipment Test Engineer Nuclear Fuels Reclamation Engineer Nuclear Fuels Research Engineer Nuclear Health Physicist
Ireland About Blog Disrupting Alzheimer's is committed to researching, developing and implementing new strategies that support independent living for those affected by Alzheimer's and other neurological diseases.
New research points to significant transformations in neurological structure and function.